POWDER DOSING CLOSURE
    3.
    发明申请
    POWDER DOSING CLOSURE 审中-公开
    粉末剂量关闭

    公开(公告)号:WO2017095609A1

    公开(公告)日:2017-06-08

    申请号:PCT/US2016/061735

    申请日:2016-11-14

    发明人: LOVE, Margo E.,

    IPC分类号: B65D51/28

    摘要: A method and apparatus for powder dosing a nutritional composition may include a container body and a closure removably coupled to the container body. A nutritive substance may be retained between an upper portion of the container body and the closure. The nutritive substance may be released and mixed with the contents of the container body prior to consumption. The nutritive substance may be sealed prior to use in order to prevent contamination of the nutritive substance.

    摘要翻译: 用于粉末计量营养组合物的方法和设备可以包括容器主体和可移除地联接到容器主体的封闭件。 营养物质可以保持在容器主体的上部和封闭件之间。 在食用之前,营养物质可以被释放并与容器主体的内容物混合。 使用前可将营养物质密封,以防止营养物质的污染。

    REDUCING THE RISK OF AUTOIMMUNE DISEASE
    7.
    发明申请
    REDUCING THE RISK OF AUTOIMMUNE DISEASE 审中-公开
    降低自身免疫性疾病的风险

    公开(公告)号:WO2014150566A1

    公开(公告)日:2014-09-25

    申请号:PCT/US2014/023630

    申请日:2014-03-11

    IPC分类号: A61K38/01 A61P37/06

    CPC分类号: A61K38/018

    摘要: The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.

    摘要翻译: 本公开提供了通过施用包含选自酪蛋白水解产物的肽的组合物来降低自身免疫疾病风险的方法。 这种组合物可以减少自身免疫疾病的症状,并且可以是自身免疫疾病,特别是1型糖尿病的治疗。 优选地,水解产物由分子量大于500Da的肽组成。

    LOW-BUFFER NUTRITIONAL COMPOSITIONS AND USES THEREOF
    8.
    发明申请
    LOW-BUFFER NUTRITIONAL COMPOSITIONS AND USES THEREOF 审中-公开
    低缓冲营养组合物及其用途

    公开(公告)号:WO2014143481A1

    公开(公告)日:2014-09-18

    申请号:PCT/US2014/016070

    申请日:2014-02-12

    摘要: The present disclosure is directed to methods for supporting resistance to bacterial growth in the gastrointestinal tract of a subject, particularly in that of a human infant. In certain embodiments, the method comprises administering to a subject a nutritional composition that has a low buffer strength, wherein administration of said nutritional composition decreases the bacterial counts of bacteria selected from the group consisting of Enteropathogenic E. coli (EPEC), Enteroaggregative E. coli (EAEC), Cronobacter sakazakii, Salmonella enterica , and combinations thereof in the subject's gastrointestinal tract. This disclosure further relates to the manufacture and use of low-buffer nutritional compositions in methods for modulating gastric acidity and/or in methods for enhancing the rate of gastric emptying in a subject, each method comprising a step of administering at least one of said low-buffer nutritional compositions to the subject.

    摘要翻译: 本公开涉及用于支持对受试者的胃肠道中的细菌生长的抗性的方法,特别是对于婴儿。 在某些实施方案中,所述方法包括对受试者施用具有低缓冲强度的营养组合物,其中所述营养组合物的施用降低了选自肠病毒性肠杆菌(Enterec病原性大肠杆菌)(Entercathogenic E.coli)(EPEC),肠聚集体E. 大肠杆菌(EAEC),阪崎肠埃布杆菌,肠炎沙门氏菌及其组合在受试者的胃肠道中。 本公开还涉及在调节胃酸度的方法中和/或用于增强受试者胃排空速率的方法中制备和使用低缓冲营养组合物,每种方法包括施用至少一种所述低浓度 缓冲营养组合物。

    NUTRITIONAL COMPOSITIONS CONTAINING AN ENRICHED LIPID FRACTION AND USES THEREOF
    9.
    发明申请
    NUTRITIONAL COMPOSITIONS CONTAINING AN ENRICHED LIPID FRACTION AND USES THEREOF 审中-公开
    含有丰富脂质分解的营养组合物及其用途

    公开(公告)号:WO2014143469A1

    公开(公告)日:2014-09-18

    申请号:PCT/US2014/015775

    申请日:2014-02-11

    摘要: The present disclosure relates to a nutritional composition comprising a fat source that includes an enriched lipid fraction derived from milk. The enriched lipid fraction may contain saturated fatty acids, trans-fatty acids, monounsaturated fatty acids, CLAs, BCFAs, cholesterol, milk fat globule membrane proteins, gangliosides, and mixtures thereof. The enriched lipid fraction may exhibit additive or synergistic beneficial health effects when consumed. The disclosure further relates to methods of providing a nutritional composition comprising an enriched lipid fraction to targeted subjects.

    摘要翻译: 本公开涉及包含脂肪源的营养组合物,其包含来自牛奶的富集的脂质部分。 富集的脂质部分可以含有饱和脂肪酸,反式脂肪酸,单不饱和脂肪酸,CLA,BCFA,胆固醇,乳脂肪球膜蛋白,神经节苷脂及其混合物。 当消耗时,富集的脂质部分可能表现出增加的或协同的有益的健康影响。 本公开还涉及向目标受试者提供包含富集脂质部分的营养组合物的方法。